Results 231 to 240 of about 734,103 (389)
ABSTRACT Pancreatic medullary carcinoma is an extremely rare tumor classified as a histological subtype of pancreatic ductal adenocarcinoma. We report a case of a pancreatic medullary carcinoma and describe its cytological features. A 75‐year‐old woman presented with lower back pain, epigastric discomfort, and a tumor‐like lesion in the pancreatic body.
Urara Okawa +4 more
wiley +1 more source
Diagnostic and prognostic values of circulating growth differentiation factor-15 and osteopontin in uterine sarcoma. [PDF]
Tsuyoshi H +5 more
europepmc +1 more source
ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang +4 more
wiley +1 more source
Addressing and supporting the unmet needs of sarcoma survivors: a qualitative study. [PDF]
Fauske L, Bruland Ø, Hompland I.
europepmc +1 more source
Pulmonary Histiocytic Sarcoma in Two Aged Dogs of a Beagle Colony
Kazuyoshi Kumagai +4 more
openalex +2 more sources
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
J. Russo +10 more
semanticscholar +1 more source
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito +9 more
wiley +1 more source
Gelatin-Based Soft-Tissue Sarcoma Organoids Recapitulate Patient Tumor Characteristics. [PDF]
Han K +12 more
europepmc +1 more source
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source

